Inhibrx Biosciences (INBX) Tax Rate (2024)
Inhibrx Biosciences' Tax Rate was -0.01% in Q2 2026, unchanged from -0.01% a year earlier.
Powered by 
Analysis
Inhibrx Biosciences (INBX) Tax Rate (2024) Analysis & Trends
On a trailing twelve-month basis, Inhibrx Biosciences' Tax Rate was 0.00% through Jun 30, 2026, unchanged year-over-year; for FY2025, it came in at 0.00%, unchanged from FY2024.
- In earlier years, Tax Rate was 0.00% in FY2024 (unchanged) and 0.00% in FY2023.
- The Q2 2026 figure marks the lowest quarterly Tax Rate since Q2 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 17.98% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 15.47% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | - |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 14.20% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | - |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 20.98% |
| 10 | Inhibrx Biosciences | 1.54 Bn | 1.54 Bn | - | - |
API Access
Inhibrx Biosciences Tax Rate API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=tax-rate&ticker=INBX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "tax-rate", "ticker": "INBX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=tax-rate&ticker=INBX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();